Martin Plöderl

@ploederl.bsky.social

Clinical psychologist and psychotherapist, part-time researcher with a focus on suicide prevention and psychopharmacology. https://ploederlm.github.io/publications/ https://scholar.google.at/citations?user=76cO6AEAAAAJ&hl=de Nature, espresso, cycling.

This paper cites our meta-analysis of RCTs (!) on antidepressant and suicidal behavior where we found a signal for harm. "Counterintuitively, and without evidence of causality, some even infer that the treatments themselves cause suicide" So they have no clue about RCTs. Peinlich.

Suicide prediction, prevention, and the blame culture: A narrative review based on trends in mortality rates | European Psychiatry | Cambridge Core

Suicide prediction, prevention, and the blame culture: A narrative review based on trends in mortality rates - Volume 68 Issue 1

cambridge.org

Canadian politician Bill Oliver has gone viral after he appeared to accidentally read AI-generated editing instructions aloud, not once, but twice, during a speech to lawmakers in early June.

It is incredibly difficult to show that national suicide prevention programs can reduce suicide rates, as discussed in this review of related studies. What I miss: most programs include awareness programs, and there is recent evidence for iatrogenic effects of such programs.

Evaluating the outcomes of national suicide prevention strategies: evidence and challenges

The public health approach to suicide prevention recognises the importance of maintaining a whole-of-government policy focus. In many countries, this focus is achieved through the planning and impleme...

thelancet.com

I'm reposting this after discovering more problems (thanks @ploederl.bsky.social). BOTTOM LINE: No trials have tested antidepressants in preschool children. This one has major flaws, including some that erode trust in the whole paper. See why psych-partners.com/fluoxetine-f... #psychiatry #pmhnp

Fluoxetine: A Problematic Trial in Ages 4-6 - PsychPartners

The first trial to test fluoxetine (Prozac) in children as young as four with major depression. See the results, the safety signal that didn't match the data, and what to do next.

psych-partners.com

Chris Aiken, MD@chrisaikenmd.bsky.social · 3w ago

Here's the first trial to test fluoxetine for #depression in children under 6: psych-partners.com/fluoxetine-f... Positive signal, but agitation is a risk, and a single study doesn't change the fact that Parent-Child Interaction #Therapy has the best evidence in this age group. #psychiatry #pmhnp

'If transporting an 80-kg person requires a vehicle weighing 1,500 kgs that consumes a 100 times as much energy, then from an energy perspective, that is absurd. However, the brain calculates this quite differently; all that matters there is saving one's own bodily energy—walking' #hermannknoflacher

8/ @JonasRueppel gives an insight how psychiatry keeps on promising a future of personalized treatment, despite the past/ongoing failures. He points out strategies/arguments to keep this promise alive. He used papers and interviews with psychiatrists working in biomarker research

1. It is concerning that, in an editorial of a leading psychiatric journal, there is a discussion of treatment effect heterogeneity, w/o distinguishing appropriate studies from those which simply looked at associations of variables with reponse/nonresponse without a placebo control group.

Editorial: Toward More Individualized Treatment of Pediatric Depression

For decades, antidepressant trials in children and adolescents have been designed to answer the question: does the medication work better than placebo? As clinicians, however, we confront a different ...

jaacap.org

Does the (live) shingles vaccine protect against dementia? Fergus Hamilton and colleagues provide important evidence in a new preprint using hospital data from the whole of England in a regression discontinuity design from which we *don't* show evidence of a meaningful protective effect /cont

Bild

Another depression study from Iran with implausible findings: - standard deviations too small - effect sizes too large (not impossible, but suspicious) - miscalculated effect size (at least for 6 weeks). They also referenced a retracted paper (even flagged as such on the journal homepage).

Rosiglitazone Adjunct to Sertraline for Major Depressive Disorder: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Insufficient responses to available treatments for major depressive disorder (MDD) underscores the necessity for innovative therapeutic strategies. This study investigated the efficacy of adjunctive ....

onlinelibrary.wiley.com

For adults, DSM-IV deleted the time requirement for Social Anxiety Disorder. The checklist expanded. More people fit it. Wonder why the diagnosis feels so common now? This is a key reason. Pro-history, not anti-therapy. Talk to professionals. Read the sources. DSM-III, 1980, DSM-IV, 1994

Before 1980: 3 doors locked. No billing code. No pharma market. No diagnosis calling shyness an illness. 1980: ∼15 psychs voted yes on DSM-III 300.23. One vote unlocked insurance, pharma, identity. Behavior existed. Billion-dollar industries didn’t. Pro-history, not anti-therapy.

1. We wrote a letter to the editor about this fluoxetine trial for children aged 4-6. Given the urgency and the expected delay in response, we also published it as a preprint, available here: doi.org/10.31234/osf... Which problems did we detect with this study ? 🧵

Chris Aiken, MD@chrisaikenmd.bsky.social · 3w ago

Here's the first trial to test fluoxetine for #depression in children under 6: psych-partners.com/fluoxetine-f... Positive signal, but agitation is a risk, and a single study doesn't change the fact that Parent-Child Interaction #Therapy has the best evidence in this age group. #psychiatry #pmhnp